Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,193 | 161 | 97.2% |
| Education | $91.02 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $621.35 | 45 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $590.68 | 23 | $0 (2024) |
| Novo Nordisk Inc | $372.02 | 17 | $0 (2022) |
| GlaxoSmithKline, LLC. | $181.06 | 5 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $171.46 | 7 | $0 (2023) |
| Abbott Laboratories | $149.14 | 3 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $144.75 | 8 | $0 (2024) |
| Amgen Inc. | $107.29 | 6 | $0 (2024) |
| PFIZER INC. | $104.81 | 6 | $0 (2022) |
| Astellas Pharma US Inc | $102.45 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $259.95 | 9 | AstraZeneca Pharmaceuticals LP ($132.72) |
| 2023 | $390.88 | 19 | Janssen Pharmaceuticals, Inc ($106.56) |
| 2022 | $379.91 | 20 | Bayer HealthCare Pharmaceuticals Inc. ($98.03) |
| 2021 | $570.00 | 21 | AstraZeneca Pharmaceuticals LP ($201.20) |
| 2020 | $414.00 | 23 | AstraZeneca Pharmaceuticals LP ($133.46) |
| 2019 | $247.62 | 15 | Janssen Pharmaceuticals, Inc ($79.07) |
| 2018 | $398.71 | 14 | GlaxoSmithKline, LLC. ($123.19) |
| 2017 | $622.64 | 42 | Janssen Pharmaceuticals, Inc ($196.62) |
All Payment Transactions
163 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/23/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Hematology | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.57 | General |
| Category: Gastroenterology | ||||||
| 07/15/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Inflammation | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESPIRATORY | ||||||
| 05/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Gastroenterology | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $115.11 | General |
| Category: Respiratory | ||||||
| 12/20/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Gastroenterology | ||||||
| 12/13/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Inflammation | ||||||
| 12/12/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: UROLOGY | ||||||
| 11/01/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Inflammation | ||||||
| 10/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: RESPIRATORY | ||||||
| 10/11/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 09/13/2023 | Coala Life Inc | Coala Heart Monitor (Device) | Food and Beverage | Cash or cash equivalent | $20.26 | General |
| Category: Cardiology | ||||||
| 08/24/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Oncology | ||||||
| 05/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/27/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 03/22/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.69 | General |
| Category: Cardio-renal | ||||||
| 03/08/2023 | Merck Sharp & Dohme LLC | JANUVIA (Drug), VERQUVO, VERQUVO | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: ENDOCRINOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 302 | 536 | $112,264 | $49,474 |
| 2022 | 9 | 415 | 760 | $157,229 | $70,127 |
| 2021 | 11 | 509 | 934 | $186,528 | $83,112 |
| 2020 | 11 | 488 | 1,094 | $228,599 | $83,243 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 142 | $42,884 | $18,593 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 201 | $50,250 | $18,268 | 36.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $10,800 | $5,882 | 54.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 43 | 43 | $4,085 | $3,563 | 87.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 56 | $3,265 | $2,261 | 69.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 49 | 49 | $980.00 | $907.48 | 92.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 343 | $85,750 | $31,738 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 54 | 113 | $34,126 | $15,671 | 45.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $15,120 | $8,441 | 55.8% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 57 | 58 | $5,510 | $4,970 | 90.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 12 | 14 | $4,200 | $3,204 | 76.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 54 | 61 | $3,355 | $2,444 | 72.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 34 | $6,800 | $2,366 | 34.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 62 | 62 | $1,240 | $1,161 | 93.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $1,128 | $131.53 | 11.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 96 | 459 | $114,750 | $43,423 | 37.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 49 | 84 | $25,368 | $12,014 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 70 | 70 | $16,800 | $9,632 | 57.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 64 | 64 | $6,080 | $5,550 | 91.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 21 | $6,300 | $4,849 | 77.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 32 | 47 | $9,400 | $3,106 | 33.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 59 | 63 | $3,465 | $2,415 | 69.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 70 | 70 | $1,400 | $1,341 | 95.8% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 12 | 13 | $520.00 | $520.00 | 100.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 25 | 26 | $2,444 | $262.29 | 10.7% |
About Dr. Manuel Bornia, MD
Dr. Manuel Bornia, MD is a Specialist healthcare provider based in Atlantis, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1073571063.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Bornia, MD has received a total of $3,284 in payments from pharmaceutical and medical device companies, with $259.95 received in 2024. These payments were reported across 163 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,193).
As a Medicare-enrolled provider, Bornia has provided services to 1,714 Medicare beneficiaries, totaling 3,324 services with total Medicare billing of $285,956. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Internal Medicine
- Location Atlantis, FL
- Active Since 05/02/2006
- Last Updated 10/17/2022
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073571063
Products in Payments
- FARXIGA (Drug) $463.10
- XARELTO (Drug) $317.67
- INVOKANA (Drug) $289.39
- TRELEGY ELLIPTA (Drug) $181.06
- Kerendia (Drug) $171.46
- XIFAXAN (Drug) $144.75
- Victoza (Drug) $132.61
- AIRSUPRA (Drug) $115.11
- Supera peripheral stent system (Device) $111.91
- Ozempic (Drug) $98.12
- NEXLETOL (Drug) $97.34
- GEMTESA (Drug) $92.35
- Vascepa (Drug) $75.75
- ELIQUIS (Drug) $68.48
- TOUJEO (Drug) $63.50
- ENTRESTO (Drug) $56.55
- Otezla (Drug) $46.30
- JANUVIA (Drug) $43.17
- Prolia (Biological) $42.62
- TRULICITY (Drug) $33.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Atlantis
Dr. Howard Routman, D.o, D.O
Specialist — Payments: $2.1M
Dr. Jose Arrascue, M.d, M.D
Specialist — Payments: $55,545
Dr. Ross Stone, M.d, M.D
Specialist — Payments: $42,078
Dr. Marco Farias, M.d, M.D
Specialist — Payments: $6,536
Dr. Osvaldo Valenzuela, M.d, M.D
Specialist — Payments: $4,499
Dr. Jhon Guzman-Rivera, M.d, M.D
Specialist — Payments: $2,497